InVivo to end Inspire trial despite meeting primary endpoint, plans new study

January 3, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) today released updated results from the Inspire study of its neuro-spinal scaffold but said that it would not be reopening enrollment, which it paused last July, and is instead looking to a new randomized controlled trial to supplement the results.

The Cambridge, Mass.-based company said that 43.8% of the 16 living patients in the trial who had been implanted with the scaffold had reached the primary endpoint of an AIS grade improvement at six months. The objective performance criterion for he study had been a 25% AIS conversion rate, InVivo said.

The last patient to reach the primary endpoint was assessed to be AIS C motor incomplete at six months, with some motor function detected on the sacral level. Of the total seven Inspire patients who had AIS improvements at six months, five improved from complete AIS A SCI ratings to sensory incomplete AIS B SCI ratings, and two patients improved from complete AIS A SCI ratings to motor incomplete AIS C SCI ratings.

A total of two of the five patients assessed at AIS B at six months showed improvements to AIS C ratings at 1 and 2 years respectively, InVivo Therapeutics said.

The company halted enrollment last July after a third patient died shortly after being discharged from the hospital after implantation. While the death was deemed to be unrelated to the neuro-spinal scaffold or the implantation procedure, the company said it was initiating a temporary enrollment halt while it explored possible trial changes with the FDA.

In continued discussions with the FDA, InVivo said it has proposed a randomized controlled trial to supplement its existing evidence, and does not plan to re-open enrollment in the trial but will provide “additional clarity on its clinical path forward in the second quarter of 2018.”

“I am pleased to report the latest AIS conversion results from Inspire. Inspire demonstrated the surgical feasibility of neuro-spinal scaffold implantation and produced encouraging data on AIS conversions at six months compared to the objective performance criterion and natural history reported in the literature. We remain in discussions with the FDA regarding the clinical path forward in support of a Humanitarian Device Exemption filing. We are working diligently to provide clarity as expeditiously as possible as we evaluate various strategic and financing options. I look forward to providing more details on our proposed randomized controlled study in the second quarter of 2018,” acting CEO Richard Toselli said in a press release.

Last August, InVivo said it was laying off nearly 40% of its workforce, pausing its Inspire clinical trial and cutting two R&D programs as it tries to get its a pivotal study back on track.

Could this 3D bioink printer speed wound healing?
The University of Toronto is touting a new handheld 3D printer that can deposit sheets of skin to cover burn wounds and accelerate the healing process. A study, led by Richard Cheng under the supervision of Axel Guenther, published in Biofabrication revealed that the 3D printer completed successful in-vivo trials on full-thickness wounds, according to a report… […]
8 types of FDA-approved devices that treat the heart
Just starting to learn about all of the medical devices out there for treating cardiovascular diseases? The U.S. FDA has a good, basic roundup on its website of the most common types of cardiovascular devices it regulates. Here’s the list, along with the FDA’s descriptions: 1. Automated external defibrillators (AEDs) “Portable and automatic, these devices… […]
Medtronic seeks to boost surgical robotics play with Digital Surgery acquisition
Medtronic (NYSE:MDT) announced today that it has acquired Digital Surgery (London), a privately-held pioneer in surgical artificial intelligence, data and analytics, and digital education and training. Financial terms of the deal were not disclosed. Medtronic said the purchase will strengthen its robot-assisted surgical platform and its broader portfolio. The medical device giant is making a big play… […]
Solvay expands advanced materials offerings in the medtech space
Solvay, a supplier of advanced materials and specialty chemicals, announced a pair of advances that it hopes will help it expand its healthcare business. Speaking yesterday at Solvay’s booth (#2414) at MD&M West, the company’s healthcare sales development manager Rose Catherin said the new materials will help improve the performance of specialty surgical devices including… […]
11 states ask EPA to crack down on ethylene oxide emissions
Eleven state attorneys general are urging the U.S. Environmental Protection Agency to impose stricter regulations over commercial operations that emit ethylene oxide (EtO), a widely used medical device sterilant gas. The EPA, which considers EtO a carcinogen, has been fielding comments on it in light of public outcry over emissions from medtech sterilization plants during… […]
Is it possible to ‘knit’ replacement blood vessels?
A new way to replace a patient’s damaged blood vessels may be on its way, as researchers in France are figuring out a way to “knit” new vessels with a collagen-based extracellular matrix. Inserm researcher Nicolas L’Heureux and his colleagues at Inserm/Université de Bordeaux’s tissue bioengineering unit published a study in Acta Biomaterialia to outline… […]
Applied Plastics has a new website, online store
Applied Plastics (Norwood, Mass.) — maker of PTFE-coated products for advanced catheter systems — announced today that it is rebranding to improve its customer interface and support continued growth. The rebranding includes a new website, online store and refreshed brand identity. The company this week is showing off the new look and its online PTFE… […]
How to select miniature motors for surgical robotics
Surgical robotics is leveraging the same sterilizable brushless direct current (BLDC) motors already used for decades in surgical hand tools. It’s all about torque, speed and reliability — as well as sterilization requirements. Keith Halbert, Portescap Today’s surgical robotics and robotically-assisted surgical devices often require BLDC motors to meet demanding requirements. While motors and motion… […]
What is an autoclave cycle?
Keith Halbert, Portescap The most common sterilization method used in hospitals is autoclaving, also called steam sterilization. During autoclaving, surgical handtools are exposed to 100% humidity, 135ºC (275ºF) and pressure variations for up to 18 minutes. Most autoclaves also have additional vacuum cycles to facilitate steam penetration and kill viruses, fungi, bacteria, and spores that… […]
BioIntelliSense wins FDA nod for BioSticker continuous vital sign monitor
BioIntelliSense announced that it won FDA 510(k) clearance for its BioSticker on-body sensor for scalable remote care and initiated the U.S. commercial launch of the product last week. The BioSticker is designed to allow for continuous monitoring of vital signs and actionable insights to provide opportunities for early detection of potentially avoidable complications from a home… […]
Accu-Tube acquires Mercury Tube
Stainless steel tubing outfit Accu-Tube announced today that it has acquired Mercury Tube, another metal tube manufacturer in its home base of Englewood, Colo. Mercury Tube, which makes high-precision stainless steel and high nickel alloy tubing, will operate as a wholly-owned subsidiary of Accu-Tube. Financial terms of the deal were not disclosed. Get the full… […]